These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 33342311)

  • 21. Structure-Activity Relationships of Small Molecule Autotaxin Inhibitors with a Discrete Binding Mode.
    Miller LM; Keune WJ; Castagna D; Young LC; Duffy EL; Potjewyd F; Salgado-Polo F; Engel García P; Semaan D; Pritchard JM; Perrakis A; Macdonald SJ; Jamieson C; Watson AJ
    J Med Chem; 2017 Jan; 60(2):722-748. PubMed ID: 27982588
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ligand-based autotaxin pharmacophore models reflect structure-based docking results.
    Mize CD; Abbott AM; Gacasan SB; Parrill AL; Baker DL
    J Mol Graph Model; 2011 Nov; 31():76-86. PubMed ID: 21967734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacologic targeting of the ATX/LPA axis attenuates bleomycin-induced pulmonary fibrosis.
    Ninou I; Kaffe E; Müller S; Budd DC; Stevenson CS; Ullmer C; Aidinis V
    Pulm Pharmacol Ther; 2018 Oct; 52():32-40. PubMed ID: 30201409
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autotaxin-Lysophosphatidic Acid Axis Blockade Improves Inflammation by Regulating Th17 Cell Differentiation in DSS-Induced Chronic Colitis Mice.
    Dong YL; Duan XY; Liu YJ; Fan H; Xu M; Chen QY; Nan Z; Wu H; Deng SJ
    Inflammation; 2019 Oct; 42(5):1530-1541. PubMed ID: 31102124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of Autotaxin Inhibitors: An Overview of the Patent and Primary Literature.
    Castagna D; Budd DC; Macdonald SJ; Jamieson C; Watson AJ
    J Med Chem; 2016 Jun; 59(12):5604-21. PubMed ID: 26745766
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phosphodiesterase 10 (PDE10) inhibitors: an updated patent review (2014-present).
    Zagórska A
    Expert Opin Ther Pat; 2020 Feb; 30(2):147-157. PubMed ID: 31874060
    [No Abstract]   [Full Text] [Related]  

  • 27. Increased Autotaxin Levels in Severe COVID-19, Correlating with IL-6 Levels, Endothelial Dysfunction Biomarkers, and Impaired Functions of Dendritic Cells.
    Nikitopoulou I; Fanidis D; Ntatsoulis K; Moulos P; Mpekoulis G; Evangelidou M; Vassiliou AG; Dimakopoulou V; Jahaj E; Tsipilis S; Orfanos SE; Dimopoulou I; Angelakis E; Akinosoglou K; Vassilaki N; Tzouvelekis A; Kotanidou A; Aidinis V
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure-Based Discovery of Novel Chemical Classes of Autotaxin Inhibitors.
    Magkrioti C; Kaffe E; Stylianaki EA; Sidahmet C; Melagraki G; Afantitis A; Matralis AN; Aidinis V
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32977539
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design and Development of Autotaxin Inhibitors.
    Jia Y; Li Y; Xu XD; Tian Y; Shang H
    Pharmaceuticals (Basel); 2021 Nov; 14(11):. PubMed ID: 34832985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and structure-activity relationships of tyrosine-based inhibitors of autotaxin (ATX).
    East JE; Kennedy AJ; Tomsig JL; De Leon AR; Lynch KR; Macdonald TL
    Bioorg Med Chem Lett; 2010 Dec; 20(23):7132-6. PubMed ID: 20951039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autotaxin inhibition: development and application of computational tools to identify site-selective lead compounds.
    Norman DD; Ibezim A; Scott WE; White S; Parrill AL; Baker DL
    Bioorg Med Chem; 2013 Sep; 21(17):5548-60. PubMed ID: 23816044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis of novel 2-pyrrolidinone and pyrrolidine derivatives and study of their inhibitory activity against autotaxin enzyme.
    Gerokonstantis DT; Nikolaou A; Magkrioti C; Afantitis A; Aidinis V; Kokotos G; Moutevelis-Minakakis P
    Bioorg Med Chem; 2020 Jan; 28(2):115216. PubMed ID: 31864778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pleotropic Roles of Autotaxin in the Nervous System Present Opportunities for the Development of Novel Therapeutics for Neurological Diseases.
    Herr DR; Chew WS; Satish RL; Ong WY
    Mol Neurobiol; 2020 Jan; 57(1):372-392. PubMed ID: 31364025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Highly Potent Non-Carboxylic Acid Autotaxin Inhibitors Reduce Melanoma Metastasis and Chemotherapeutic Resistance of Breast Cancer Stem Cells.
    Banerjee S; Norman DD; Lee SC; Parrill AL; Pham TC; Baker DL; Tigyi GJ; Miller DD
    J Med Chem; 2017 Feb; 60(4):1309-1324. PubMed ID: 28112925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Computer Aided Drug Design Approaches for Identification of Novel Autotaxin (ATX) Inhibitors.
    Vrontaki E; Melagraki G; Kaffe E; Mavromoustakos T; Kokotos G; Aidinis V; Afantitis A
    Curr Med Chem; 2016; 23(17):1708-24. PubMed ID: 26997151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of autotaxin inhibitors: A series of zinc binding triazoles.
    Thomson CG; Le Grand D; Dowling M; Brocklehurst CE; Chinn C; Elphick L; Faller M; Freeman M; Furminger V; Gasser C; Hamadi A; Hardaker E; Head V; Hill JC; Janus DI; Pearce D; Poulaud AS; Stanley E; Sviridenko L
    Bioorg Med Chem Lett; 2018 Jul; 28(13):2279-2284. PubMed ID: 29798825
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Expression Regulation and Biological Function of Autotaxin.
    Zhang X; Li M; Yin N; Zhang J
    Cells; 2021 Apr; 10(4):. PubMed ID: 33921676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of Novel Indole-Based Allosteric Highly Potent ATX Inhibitors with Great
    Lei H; Guo M; Li X; Jia F; Li C; Yang Y; Cao M; Jiang N; Ma E; Zhai X
    J Med Chem; 2020 Jul; 63(13):7326-7346. PubMed ID: 32479084
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure-based design of novel boronic acid-based inhibitors of autotaxin.
    Albers HM; Hendrickx LJ; van Tol RJ; Hausmann J; Perrakis A; Ovaa H
    J Med Chem; 2011 Jul; 54(13):4619-26. PubMed ID: 21615078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular modelling guided design, synthesis and QSAR analysis of new small molecule non-lipid autotaxin inhibitors.
    Banerjee S; Norman DD; Deng S; Fakayode SO; Lee SC; Parrill AL; Li W; Miller DD; Tigyi GJ
    Bioorg Chem; 2020 Oct; 103():104188. PubMed ID: 32890995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.